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Abstract
Although chest radiograph (CXR) is commonly used in diagnosing pediatric com-
munity acquired pneumonia (pCAP), limited data on interobserver agreement
among radiologists exist. PedCAPNETZ is a prospective, observational, and multi-
center study on pCAP. N = 233 CXR from patients with clinical diagnosis of pCAP
were retrieved and n = 12 CXR without pathological findings were added. All CXR
were interpreted by a radiologist at the site of recruitment and by two external,
blinded pediatric radiologists. To evaluate interobserver agreement, the reporting
of presence or absence of pCAP in CXR was analyzed, and prevalence and bias‐
adjusted kappa (PABAK) statistical testing was applied. Overall, n = 190 (82%) of
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CXR were confirmed as pCAP by two external pediatric radiologists. Compared with
patients with pCAP negative CXR, patients with CXR‐confirmed pCAP displayed
higher C‐reactive protein levels and a longer duration of symptoms before enroll-
ment (p < .007). Further parameters, that is, age, respiratory rate, and oxygen sa-
turation showed no significant difference. The interobserver agreement between
the onsite radiologists and each of the two independent pediatric radiologists for
the presence of pCAP was poor to fair (69%; PABAK = 0.39% and 76%; PABAK =
0.53, respectively). The concordance between the external radiologists was fair
(81%; PABAK = 0.62). With regard to typical CXR findings for pCAP, chance cor-
rected interrater agreement was highest for pleural effusions, infiltrates, and con-
solidations and lowest for interstitial patterns and peribronchial thickening. Our
data show a poor interobserver agreement in the CXR‐based diagnosis of pCAP and
emphasized the need for harmonized interpretation standards.
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antibiotic therapy, imaging, infections: pneumonia, TB, viral
1 | INTRODUCTION
Pediatric community‐acquired pneumonia (pCAP) is the most com-
mon infectious disease in children aged 1–59 months, causing sub-
stantial global morbidity and mortality.1 Hospital admissions in
children with pCAP is a considerable burden on healthcare systems
worldwide.2 In Europe, pCAP affects 30/10,000 children and ado-
lescents until the age of 16 years.3 The incidence is inversely cor-
related with age, ranging from 111/10,000 in the first year of life to
25/10,000 in early childhood (2–5 years) to 12.5/10,000 in school‐
aged children (5–16 years).4 Disease patterns vary in localization,
degree of infestation, and age of the child.5,6
Chest radiograph (CXR) remains the most available and common
imaging modality to confirm the diagnosis and classify pCAP in
children.7,8 pCAP typically presents radiologically as one of three
patterns: “lobar pneumonia,” “multifocal bronchopneumonia,” and
focal or diffuse “interstitial pneumonia.” These patterns allow dis-
tinction from other forms of lower respiratory tract infections such
as bronchiolitis.9 Although guidelines suggest that CXR should not
routinely performed in mild or uncomplicated cases of pCAP,10–12 it
is still commonly performed in children.10 CXR is not routinely re-
commended in the outpatient setting due to a lack of evidence for
substantial impact on clinical outcomes.13 However, radiographic
findings can provide useful prognostic information and may predict
disease severity.14,15 Although CXR is used to confirm the diagnosis
of pCAP, the variability in diagnosing pCAP based on CXR including
the interobserver agreement among pediatric radiologists is a re-
cognized problem.16–18 While radiographic findings are commonly
accepted as the gold standard for diagnosing pCAP, there are no
validated definitions for CXR interpretation in clinical practice.7
Therefore, the aim of this investigation was to analyze interobserver
agreement in the interpretation of CXR for the diagnosis of pCAP in
children in Germany. Specifically, we wonder whether CXR‐based
diagnosis of pCAP in a multicenter study design needs to be revised
by independent external reviewers.
2 | METHODS
2.1 | Study design and participants
Between December 2014 and July 2017, study data of n = 233 pa-
tients with pCAP were collected in private practices, outpatient
clinics, and hospitals across Germany as part of the pedCAPNETZ
study, an observational, multicenter study on pCAP.19 All patients or
their legal guardians gave informed consent to participate in this
study. Inclusion criteria for inclusion into the analysis were the
presence of at least one of the following signs or symptoms: cough,
tachypnea, fever, or abnormal findings on auscultation plus pCAP
radiographically confirmed by a local radiologist at the site of re-
cruitment.19 Exclusion criteria were hospitalization for any other
reason within the last 28 days, congenital or acquired im-
munodeficiency, cytostatic therapy during past 28 days, neutropenia
(<1000/μl), other relevant immunosuppressive treatment, a con-
comitant respiratory disease with impaired mucociliary clearance
such as cystic fibrosis, primary ciliary dyskinesia, tracheostomy, or
other severe lung diseases including pulmonary tuberculosis.19
2.2 | Clinical history and laboratory procedures
Detailed data on demographic background, case history, clinical
presentation, quality of life, physical examination, diagnostic
findings, treatment, socioeconomic measures, and other patient‐
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related items were collected by means of an electronical case
report form.19 Moreover extensive biosampling is conducted in-
cluding the collection of blood sample, nasopharyngeal aspirate
or swab in the upper airway tract (UAT), and sputum or deep
throat swab in the lower airway tract (LAT).19 Spectrum of pa-
thogen of pCAP is studied in the collected biosamples of the UAT,
LAT by Multiplex polymerase chain reaction (PCR) pathogen
screen (Multiplex panel see Table S2) and microbiome culture.19
Nasopharyngeal swabs were analyzed using a multiplex real‐time
RT‐PCR panel according to Bierbaum et al.20 This included
testing for respiratory viruses (adenovirus, bocavirus, cor-
onavirus [CoV] OC43, CoV 229E, CoV HKU1, CoV NL63, en-
terovirus, influenza virus A+B, human metapneumonvirus,
parainfluenza virus 1–4, human parechovirus, respiratory syn-
cytial virus A+B, and rhinovirus) and atypical bacteria (Bordetella
pertussis, Legionella pneumophila, and Mycoplasma pneumoniae).
Microbial cultures of respiratory samples were performed to
standard laboratory procedures in each center (certified clinical
microbiology departments).
2.3 | Evaluation of CXR
A total of n = 245 CXR were rated by a local radiologist. Images were
downloaded as Digital Imaging and Communications in Medicine
(DICOM) images from the hospital&#39;s Picture Archiving and
Communication System (PACS, Picture Archiving and Communica-
tion System/IMPAX EE R20 XVII/Agfa HealthCare/Belgium). After
pseudonymization using IQ View 3.0 Image information system (IQ
View Image information system/3.0. trial version/IMAGE Informa-
tion Systems Europe GmbH/Germany), two independent specialized
pediatric radiologists reviewed all images and completed a standar-
dized CXR interpretation form (Table S1). Main outcome measure
was the presence or absence of pCAP on radiographs, defined as
evidence of an infiltrate. Furthermore, we analyzed the interobserver
agreement of radiographic findings commonly described in childhood
pneumonia. Therefore, the two independent radiologists were re-
quested to report diagnostic findings using the clinical
pedCAPNETZ‐item‐catalog (peribronchial thickening, interstitial
pattern, infiltrate, atelectasis, and dystelectasis, pleural effusion19)
TABLE 1 Interobserver agreement of pediatric radiologists, prevalence and bias‐adjusted kappa (PABAK) with 95% confidence interval










Local pediatric radiologists/external pediatric
radiologist (1)a
76 0.53 0.41–0.63 0.23 0.15–0.31
Local pediatric radiologists/external pediatric
radiologist (2)a
69 0.39 0.26–0.50 0.17 0.10–0.24
External pediatric radiologist (1)/external
pediatric radiologist (2)a
81 0.62 0.51–0.71 0.56 0.44–0.69
Radiographic changes: WHO‐Classification21
Consolidationb 75 0.49 0.37–0.60 0.45 0.33–0.58
Other infiltratesb 57 0.13 0.00–0.26 0.14 0.02–0.25
Pleural effusionb 88 0.76 0.67–0.84 0.64 0.52–0.77
Radiographic changes:pedCAPNETZ‐item‐catalogue
Peribronchial thickeningb 62 0.25 0.11–0.37 0.23 0.10–0.36
Interstitial patternb 64 0.28 0.15–0.41 0.17 0.06–0.29
Hyperinflationb 71 0.41 0.29–0.53 0.41 0.28–0.54
Infiltrateb 80 0.59 0.48–0.69 0.51 0.38–0.63
Atelectasis/dystelectasisb 72 0.45 0.32–0.56 0.25 0.12–0.38
Pleural effusionb 88 0.76 0.66–0.84 0.64 0.52–0.77
Radiographic pattern
Lobar pneumoniab 88 0.75 0.65–0.83 0.56 0.43–0.69
Bronchopneumoniab 78 0.55 0.43–0.66 0.30 0.17–0.42
Interstitial pneumoniab 84 0.68 0.57–0.77 0.03 −0.09 to 0.14
aInterobserver agreement in the interpretation of CXR for the diagnosis of pCAP by local pediatric radiologists and two external pediatric radiologists.
bInterobserver agreement of radiographic findings commonly described in childhood pneumonia by two external pediatric radiologists.
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and the WHO‐classification (consolidation, other infiltrates, and
pleural effusion21). In addition to describing individual diagnostic
findings, pediatric radiologists were asked to further classify CXR
based pCAP diagnoses into specific subtypes: lobar pneumonia,
bronchopneumonia, interstitial pneumonia,9 or “other pattern” (-
Table 1). In addition, normal chest X‐rays from healthy controls were
randomly placed into the conspicuous chest radiographs of children
with clinical pneumonia. In contrast to the local radiologists, who
judged the chest X‐rays based on clinical information, the two ex-
ternal radiologists independently read all chest radiographs and were
blinded to each other&#39;s interpretations.
2.4 | Statistical analysis
Data analysis was performed using Statistical Package for the
Social Sciences (SPSS,22) and R V4.0.3.23 Interobserver agree-
ment was assessed using observed percent agreement, pre-
valence and bias‐adjusted kappa (PABAK) with 95% confidence
interval24 and Cohens Kappa (κ) with 95% confidence interval.
The interpretation of PABAK and Cohens Kappa is based on the
criteria (<0.41: poor, <0.75: fair, and <1: excellent) defined by
Fleiss.23 Next, we assessed interobserver agreement specifically
for different radiographic findings in our investigation. Based on
the main outcome measure children were divided into two
groups. Children with radiographic confirmed pCAP by both or at
least one external pediatric radiologist were classified as
“pneumonia.” Children with CXR judged as negative for pCAP by
both external pediatric radiologists were classified as “non‐
pneumonia.” Depending on data distribution, Mann–Whitney‐U‐
or t‐testing was samples were applied to assess differences
between these two groups. In addition, viral and bacterial etiol-
ogy of pCAP was studied in the collected bio samples of the UAT,
LAT, and urogenital tract. The groups of pneumonia and non-
pneumonia were descriptively compared regarding previously
described biosamples.
3 | RESULTS
Characteristics of the study population are shown in Table 2. The
median age of children with clinical signs of pCAP included into this
analysis was 2 years (n = 233, range 1 month–17 years, interquartile
range [IQR] 1–6 years), and 47% were female. Nearly all children
(97%) suffered from cough and 85% presented with fever at the
enrollment visit. For control purposes, n = 12 CXR of children with-
out findings suspicious of pCAP were added. Their median age was
3.5 years (IQR 1.3–12) and 67% were female.
All radiologists agreed that all chest radiographs were suitable
for interpretation. All 12 control CXR were assessed by the two
external radiologists as inconspicuous for pCAP. Amongst the CXR of
the pCAP patients, n = 190 (82%) CXR were assigned as “pneumonia”
by at least two out of three involved radiologists (Figure 1).
Interobserver agreement between radiologists was assessed
using observed percent agreement, the PABAK and Cohens
Kappa (κ) in the main outcome measure presence or absence of
pneumonia on radiographs. Our results and calculated inter-
observer agreement for various findings and categories are
presented in Tables 3 and 1 and in Supplement (S2–S4). Chest X‐
ray examples for selected pathologies listed in the tables showing
agreement and disagreement between reviewers are displayed in
Figure 2.




n = 233 (95%)
Study cites
Healthy controls
n = 12 (5%)
Lübeck
n = 99 (43%)
Hannover
n = 71 (31%)
Oldenburg
n = 49 (21%)
Dresden
n = 14 (6%)
Gender: male n (%) 124 (53) 51 (52) 40 (56) 25 (51) 8 (57) 4 (33)
Age, years median (IQR) 2 (1–6) 2 (1–4) 3 (1–6) 3 (1.5–5.5) 2 (1–9) 3.5 (1.3–12)
Inpatient n (%) 189 (81) 96 (97) 31 (44) 49 (100) 13 (93) n.a.
Clinical signs and symptoms
Cough n (%) 225 (97) 96 (97) 71 (100) 45 (92) 13 (93) n.a.
Tachypnea* n (%) 130 (56) 66 (67) 28 (39) 27 (55) 9 (64) n.a.
Abnormal findings on
auscultation n (%)
203 (87) 85 (86) 61 (86) 45 (92) 12 (86) n.a.
Fever** n (%) 199 (85) 87 (88) 59 (83) 39 (80) 14 (100) n.a.
Abbreviation: IQR, interquartile range.
*Tachypnea (respiratory rate > 60/min for infants less than 2 month old; respiratory rate > 50/min for children aged 2–11 months; respiratory rate: > 40/
min for those 1–18 years old)3,25
**Fever (≥ 38.5°C [rectal] or 38.0°C [tympanic, axillary, and oral]).19
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Next, we analyzed whether the children with CXR confirmed
pCAP (grouped as “pneumonia”) displayed a distinct phenotype
from those children with CXR judged as “no pneumonia.” Indeed,
patients in the CXR confirmed “pneumonia” group displayed
higher C‐reactive protein levels and longer symptom duration
before enrollment (Table 4). The radiological findings showed
that consolidation was exclusively ascribed in the group of
pneumonia. Further parameters such as age, temperature,
respiratory rate, oxygen saturation, and white blood cell count
demonstrated no significant difference.
To analyze the pathogenic spectra, viral and bacterial pathogens
were studied in the UAT and the lower airway tract by multiplex PCR
(UAT: n = 216 children; 93%; LAT: n = 184; 79%) and microbiological
culture (UAT: n = 69; 30%; LAT n = 198; 85%).
Overall a potential causative agent was found in 74% and 66% of
the conducted multiplex PCR of the UAT and LAT, respectively, while
conventional culture revealed 62% and 58% positive results. We
observed no significant differences between the confirmed versus no
pneumonia groups in terms of numbers or patterns of identified
pathogens in UAT or LAT samples (Table 5).
4 | DISCUSSION
This study shows high interrater variability in the interpretation of
CXR for the diagnosis of pCAP. This may be a significant confounder
variable in multicenter trials. Two independent, external, blinded
pediatric radiologists rejected 18% of the CXR‐based pCAP diag-
noses in a large cohort of children and adolescents. Chance adjusted
agreement between local pediatric radiologists and the two external
pediatric radiologists was poor. The interobserver agreement
showed high variability between the study sites.
Our result highlights the need to revise the CXR‐based diagnosis
of pCAP in a multicenter study design. Based on our data we ad-
ditionally suggest using standardized radiographic interpretation
forms in the initial assessment and to set up a compulsory training
course in multicenter studies. A modified pedCAPNETZ‐item‐
catalogue19 can be used to further evaluated and improve the in-
terobserver agreement.
One of the aims of the pedCAPNETZ study is to characterize
children and adolescents with pCAP using comprehensive epide-
miological, clinical, and biological analyses to improve care and
F IGURE 1 Course of study. D, Dresden; H, Hannover; HL, Study center Luebeck; O, Oldenburg [Color figure can be viewed at
wileyonlinelibrary.com]
TABLE 3 Concordance analysis on the question of pneumonia
between the local radiologist and external pediatric radiologist 1





No 12 0 12
Yes 58 175 233
Total 70 175 245





No 12 0 12
Yes 75 158 233
Total 87 158 245
Note: Observer agreement = 69%, PABAK = 0.39, κ= 0.17.




No 55 15 70
Yes 32 143 175
Total 87 158 245
Note: The observer agreement, the prevalence and bias‐adjusted kappa
(PABAK) and Cohens Kappa (κ) is reported. Observer agreement = 81%,
PABAK = 0.62, κ = 0.56.
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F IGURE 2 X‐ray examples for selected pathologies listed in table showing agreement (upper row) and disagreement (lower row) between
reviewers: (A) bronchopneumonia, (B) consolidation, (C) interstitial pneumonia, (D) lobar pneumonia, and (E) other infiltrates [Color figure can
be viewed at wileyonlinelibrary.com]
TABLE 4 Patient characteristics in






(n = 43) p value
Age, years median (IQR) 2.5 (1–6) 1 (1–5) .173
Days since onset of symptoms
median (IQR)
5 (3–9) 3 (1–6) .004
Highest temperature median (IQR) 39.6 (39–40) 39.5 (39–40) .918
Respiratory rates/min mean (SD) 41 (15.73) 46.7 (21.45) .178
SpO2 in % median (IQR) 95 (90–97) 93 (91–95) .353
Leukocytes 10³/μl median (IQR) 13 (10–19) 13 (9–15) .116
CRP g/dL median (IQR) 34 (10–84) 14 (5–41) .003
Abbreviations: CRP, C‐reactive protein; IQR, interquartile range.
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TABLE 5 Detected viral and bacterial pathogens in upper and lower airways of children with radiological confirmed pCAP and
nonconfirmed pCAP
Location Upper airway tract Lower airway tract
Group All n (%) Pneumonia n (%) Nonpneumonia n (%) All n (%) Pneumonia n (%) Nonpneumonia n (%)
PCRa 160 129 31 122 97 25
RSV A/B 50 (21) 41 (21) 9 (19) 35 (25) 26 (23) 9 (30)
Rhinovirus 39 (16) 29 (15) 10 (21) 18 (13) 15 (14) 3 (10)
Human bocavirus 33 (14) 26 (13) 7 (14) 14 (10) 10 (9) 4 (13)
Mycoplasma pneumoniae 30 (13) 27 (14) 3 (6) 30 (21) 28 (25) 2 (6)
Human metapneumovirus A/B 20 (8) 15 (8) 5 (11) 7 (5) 3 (3) 4 (13)
Human coronavirus (HKU 1, NL 63,
229E, OC43)
17 (7) 14 (7) 3 (6) 9 (6) 7 (6) 2 (7)
Parainfluenzavirus 16 (7) 13 (7) 3 (6) 5 (4) 5 (5) 0 (0)
Adenovirus 11 (5) 9 (5) 2 (4) 1 (1) 1 (1) 0 (0)
Enterovirus 10 (4) 6 (3) 4 (9) 10 (7) 5 (5) 5 (17)
Influenza‐A‐virus 7 (3) 7 (4) 0 (0) 5 (4) 5 (5) 0 (0)
Influenza‐B‐virus 6 (3) 5 (3) 1 (2) 5 (4) 4 (4) 1 (3)
Parechovirus 1 (0) 1 (1) 0 (0) 2 (1) 2 (2) 0 (0)
Total 240 (100) 193 (100) 47 (100) 141 (100) 111 (100) 30 (100)
Microbiological culture 43 28 15 114 90 24
Haemophilus influenzae 20 (34) 12 (32) 8 (38) 34 (23) 27 (23) 7 (21)
Moraxella catarrhalis 12 (21) 7 (19) 5 (24) 2 (1) 2 (2) 0
Staphylococcus aureus 9 (16) 6 (16) 3 (14) 14 (9) 13 (11) 1 (3)
ORSA/MRSA 1 (2) 1 (3) 0 0 0 0
Streptococcus pneumoniae 6 (10) 3 (8) 3 (14) 4 (3) 3 (3) 1 (3)
Enterobacter 2 (3) 2 (5) 0 12 (8) 10 (9) 2 (6)
Pseudomonas spp. 1 (2) 1 (3) 0 1 (1) 0 1 (3)
Klebsiella oxytoca 1 (2) 1 (3) 0 5 (3) 3 (3) 2 (6)
Klebsiella pneumoniae 0 0 0 2 (1) 2 (2) 0
E. coli 0 0 0 4 (3) 1 (1) 3 (9)
Haemophilus parainfluenzae 0 0 0 23 (15) 19 (16) 4 (12)
Haemophilus spp. 0 0 0 8 (5) 4 (3) 4 (12)
Haemophilus haemolyticus 0 0 0 6 (4) 5 (4) 1 (3)
Actinetobacter spp. 0 0 0 11 (7) 8 (7) 3 (9)
Candida albicans 0 0 0 8 (5) 6 (5) 2 (6)
Othersb 6 (10) 4 (10) 2 (10) 15 (10) 13 (11) 2 (6)
Total 58 (100) 37 (100) 21 (100) 149 (100) 116 (100) 33 (100)
Note: Total numbers of detects and percentage in relation to samples with positive proof are reported.
Abbreviations: ORSA/MRSA, oxacillin‐resistant Staphylococcus aureus/methicillin‐resistant Staphylococcus aureus; pCAP, pediatric community‐acquired
pneumonia; PCR, polymerase chain reaction.
aIn some children, the multiplex PCR analyses of the upper and/or lower airway tract displayed multiple pathogenic agents. Total numbers of detects and
percentage in relation to samples with positive proof are reported.
bStreptococcus pyogenes; Streptococcus (ß‐häm) non‐A, non‐B; Streptococcus viridans; Streptococcus pyogenes; Bacillus species; Propionibacterium acnes;
Streptococcus mitis; Corynebakterium; Haemophilus parahaemolyticus; Pantoea sp.; Serratia marcescens; Stenotrophomonas maltophilia; Candida guilliermondii;
nonfermenting bacteria.
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quality of life.19 However, a concurring diagnosis is a prerequisite for
subsequent in‐depth analysis in the pedCAPNETZ cohort. Non-
specific clinical symptoms make it difficult to distinguish pneumonia
from other respiratory diseases.11 Accuracy of radiograph inter-
pretation is important for clinical decision‐making.
Similar to previous studies, chance‐adjusted diagnostic con-
cordance between external radiologists was moderate in our study.
An Australian study on variability and accuracy in interpretation of
CXR in diagnosing pCAP in more than 3000 children under the age of
five found an interobserver agreement similar to that observed in
our cohort.17 Another study from Israel focused on pediatric CXR
with discordant interpretations between emergency physician and
radiologist&#39;s final interpretation.26 A subgroup analysis of in-
terobserver agreement revealed low kappa scores comparable to
those found in our investigation with the best level of agreement
between radiologists and senior emergency physicians.
Overall, our findings are in line with previous studies of inter-
observer agreement in the interpretation of CXR for the diagnosis of
pCAP.16,27,28 However, direct comparison is limited as most studies
differ in number and age of participants, fluid intake of the child (e.g.,
for demarcation of infiltrates), extent of radiographic findings noted
in the chest radiography interpretation form, specialty of the in-
vestigator reading the CXR, or extent of further analysis of the pa-
tient characteristics and microbiological correlate.
A strength of our study lies in the multicenter study design, which
enabled the comparison of interobserver agreement between different
study sites. In addition, the detailed radiographic interpretation form
used in our analysis allowed us to compare interrater variability in high
granularity. Furthermore, the broad clinical data collection and biosam-
pling enabled us to correlate CXR based observation with multiple other
variables. Possible limitations of our work could lie in the fact that the
external radiologists, based on their knowledge of the study design, may
have been biased to diagnose pCAP. Moreover, the sample size might be
a limitation, and that is the low number of normal CXRmight have biased
our results. However, for ethical reasons, the recruitment of normal CXR
is challenging.
The interobserver agreement varied depending on specific
findings recorded in the standardized chest radiograph inter-
pretation form. We decided to include the WHO‐classification in
our standardized chest radiograph interpretation form to enable
the comparison to previous international studies about inter-
observer agreement. Similar to previous studies, pleural effusion
and consolidation are findings with high interobserver agree-
ment,29 whereas interobserver agreement regarding other in-
filtrates was poor.
Nevertheless, it is important to point out that the WHO standar-
dized criteria were developed with the goal to improve the interobserver
agreement for epidemiological studies on pneumonia and bacterial vac-
cine efficacy trials.21 The central aim of the pedCAPNETZ initiative to
analyze current applied diagnostic and therapeutic strategies in hospital
and outpatient care across Germany and evaluate their importance for
accuracy in clinical pCAP management.19 The WHO classification was
not designed for use in individual patient clinical management because of
its emphasis on specificity on bacterial pneumonia at the expense of
sensitivity for overall pCAP.
The clinical pedCAPNETZ‐item‐catalogue showed a range of
interobserver agreement from poor for the interstitial pattern to
good for the pleural effusion for its findings. Overall, pleural effusion,
infiltrate, and consolidation seemed to be the findings with most
interobserver concordance rates in CXR.
CXR should not be the driving force to decide whether e.g. an an-
tibiotic treatment is indicated. A study from Finland on the differentiation
of bacterial and viral pneumonia in children showed that an interstitial
infiltrate was likewise associated with viral and bacterial pneumonia.30
This fits our observation and is in line with other findings reporting on
nonspecific CXR patterns for different types of pCAP causing patho-
gens.31 Only for the CXR pattern of lobar pneumonia, a significant as-
sociation with bacterial infection has been described.30 There was no
significant difference between the pathogen spectrum in the group with
pneumonia and no pneumonia in our descriptive analysis. However, it
should be mentioned that a further limitation of our work is the in-
complete collection of biological samples of every patient enrolled in the
study, as we focused on analyzing interobserver agreement in the in-
terpretation of chest radiographs for pCAP. Moreover, the difficulty to
differentiate between colonization and infection of potential causative
agents remains. Nevertheless, potential causative agents concerning the
etiology of pCAP will be subject to future analysis of the pedCAPNETZ
cohort to possibly improve individual treatment and adjust the use of
antibiotics.
In conclusion, the extensive interrater variability in our study
illustrates the necessity of a standardized interpretation of CXR
for pCAP in clinical practice. This emphasizes the need for uni-
form definitions on simple criteria and adequate training to im-
prove interobserver agreement.32,33 In addition, our data
suggest that the diagnosis of pCAP should be based on the in-
tegration of a number of related observations, that is, clinical
signs and symptoms, laboratory parameters, and CXR. Clinicians
should take into account the great interrater variability of CXR
interpretation for the diagnosis pCAP when making clinical de-
cisions. Finally, our data support current guidelines suggesting
that CXR should not routinely performed in mild or un-
complicated cases of pCAP.
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